ICYMI. I wanted to share the press release from NeuroSense Therapeutics so that you can see for yourselves the data and make your own assessment of it. prnewswire.com/news-releases/…

$NRSN People are approaching us, asking for news. News coming your way! 🚀 We’ll be sharing our latest achievements, upcoming milestones, and future plans very soon. Stay tuned for updates!

It appears that coffee and business make the perfect blend ☕💼 $NRSN Alon Ben-Noon #ThePerfectBlend #FocusOnTheNow #BusinessInsights #NRSN

“The most rewarding aspect of leading NeuroSense is hearing how we have improved people’s lives” Alon Ben-Noon Check out our CEO's blog 👇 #OurStory #NeuroSenseTherapeutics #NRSN neurosense-tx.com/neurosense-fea…

Join us today at the annual NEALS meeting, where Prof. Merit Cudkowicz will be presenting key elements of Paradigm, our phase 2b clinical study

Join us today at the annual NEALS meeting, where Dr. Christian Lunetta will be presenting recent findings of our biomarker study

Exciting times ahead!

... When they asked me what is the best tip I got in carrier I immediately said-If you haven’t experienced failure, you may not be aiming high enough. Why? click to read all about it... neurosense-tx.com/neurosense-fea…

Our great VP of R&D in a worth-reading blog!

See this Instagram video by Nuseir Yassin instagram.com/reel/DCB9Q34uL…

$NRSN News: Yesterday, NeuroSense held a key meeting with the FDA, marking an exciting step forward in our journey. The meeting was very positive, and we look forward to sharing more details in an official PR after receiving the meeting minutes. Stay tuned! #ALS #FDA

Be Excited for This One Pill A few months ago, I shared Alon's mission with NeuroSense Therapeutics (Nasdaq: $NRSN) to find an ALS treatment. Now, they’re set to launch in Canada! If approved, this could mean longer, better lives for people with ALS. Now, that’s a reason to celebrate!

Join us on Thursday at the @ALSONE meeting, where Prof. Merit Cudkowicz & Dr. Shiran Zimri will share our latest results

Dedication goes beyond the office. Our CEO Alon Ben-Noon leads by example, showing that making a difference starts with small meaningful acts

$NRSN - An important note (:

A very important note 😀 $NRSN

What happens when Broadway star Aaron Lazar - now a fearless ALS advocate, sits down again with NeuroSense CEO Alon Ben-Noon, continuing a moving conversation they began not long ago? A powerful live conversation on breakthrough ALS science, PrimeC’s path to market, and hope for